WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009

WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009.

In May 2009, WHO convened a meeting of Working Group on Technical Specifications for Manufacturing and Evaluating Yellow Fever (YF) Vaccines, Geneva, Switzerland to initiate revision of the WHO Recommendations (formerly, Requirements) for YF vaccine published in WHO Technical Report Series number 872 (1998). The Working Group, consisting of experts from academia, industry, national regulatory a...

Reactogenicity of Yellow Fever Vaccines in a and Collaborative Group for the Study of Yellow Fever Vaccines*

*The name of the Collaborative Group for the study of Yellow Fever vaccines is listed in the end of the article. Abstract Objective To compare the reactogenicity of three yellow fever (YF) vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots) and placebo. Methods The study involved 1,087 adults eligible for YF vaccine in Rio de Janeiro, Brazil. Vaccines produced by Bio-Mangu...

Yellow fever vaccines: Selected references for the WHO Position

Since the 1980s, yellow fever has reemerged across Africa and in South America. The total of 18 735 yellow fever cases and 4522 deaths reported from 1987 to 1991 represents the greatest amount of yellow fever activity reported to the World Health Organization (WHO) for any 5-year period since 1948. There is an excellent vaccine against yellow fever. At present, a high proportion of travelers to...

Perinatal Transmission of Yellow Fever, Brazil, 2009

with verocytotoxin-producing Escherich-ia coli O157—10 years of serodiagno-sis. toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Esche-richia coli O26 infection in humans. To the Editor: Although urban cases of yellow fever have not been reported in Brazil since 1942, sylvatic yellow fever is still endemic to the northern and middle-western states. In the past decade, ...

WHO Technical Working Group Meeting on Revision of the WHO Recommendations for the Production and Control of Inactivated Poliomyelitis Vaccines: TRS